PURIXAN
NDC 62484-0020, Purixan, suspension, from Nova Laboratories, Ltd.
- Product NDC
- 62484-0020
- Status
- Listed
- Labeler
- Nova Laboratories, Ltd
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205919
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62484-0020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MERCAPTOPURINE20 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62484-0020-2 | 62484002002 | 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9fd27952-7787-47d9-b6cf-7af2dc38217b
Use it
Look up 62484-0020 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62484-0020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62484-0020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.